Th17 cells are the primary source of IL-17, which has been shown to attenuate hepatic steatosis by downregulating stearoyl-CoA desaturase-1 (SCD-1), while simultaneously exacerbating hepatic inflammation and fibrosis [66]. The gene discussed is IL17A; the disease is fatty liver disease.